FTO and obesity due to melanocortin 4 receptor deficiency: For instance, Yin et al. (2023) emphasized the role of FTO as a well-established obesity-associated gene, noting that its variants influence fat storage, energy balance, and metabolic disease risk through both genetic and epigenetic mechanisms, including RNA modification pathways [36].